Last reviewed · How we verify

Yifei Qinghua granule — Competitive Intelligence Brief

Yifei Qinghua granule (Yifei Qinghua granule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory / Infectious Disease.

phase 3 Respiratory / Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Yifei Qinghua granule (Yifei Qinghua granule) — Henan University of Traditional Chinese Medicine. Yifei Qinghua granule is a traditional Chinese medicine formulation that clears heat and resolves toxicity to treat respiratory and inflammatory conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Yifei Qinghua granule TARGET Yifei Qinghua granule Henan University of Traditional Chinese Medicine phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Yifei Qinghua granule — Competitive Intelligence Brief. https://druglandscape.com/ci/yifei-qinghua-granule. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: